KUALA LUMPUR, Jan 12 -- Conagen has announced its breakthrough development in the commercial production of natural, sustainable macrocyclic musk lactones from natural substrates using its proprietary technology.
This further expands its already extensive gamma-lactone portfolio, according to a statement.
“The expansion of Conagen's lactone platform to macrocyclic lactones with musk fragrances adds to our momentum in meeting consumers' demand for nature-based, clean ingredients,” said Conagen VP of innovation, Dr Casey Lippmeier.
Conagen successfully bridged its gamma-lactone production technology with its lipid platform to expand its lactone portfolio to natural musk scent macrocyclic lactones.
Built upon the diversity of structures among natural lipids, Conagen’s macrocyclic musk portfolio contains diverse compounds representing a range of familiar and novel aromas, many of which have never before been commercially available.
This variety of characteristics creates a wider spectrum of fragrance application options for manufacturers that use musk macrocyclic lactones in their products.
Over the past decade, Conagen has successfully developed one of the largest portfolios of ingredient products for its customers, including science-based Blue California ingredients.
Conagen focuses on the bioproduction of high-value ingredients for food, nutrition, flavours and fragrances, pharmaceutical, and renewable materials industries. More details at www.conagen.com.
-- BERNAMA
No comments:
Post a Comment